Healthcare Pharmaceuticals Limited (HPL) proudly presents its General Solid Production Unit, located within two advanced multi-story buildings designed to meet and exceed global pharmaceutical manufacturing standards. The facility adheres strictly to Good Manufacturing Practices (GMP) and is equipped with state-of-the-art manufacturing and packaging machinery. Comprehensive HVAC and water systems are integrated throughout the unit, alongside rigorous health and safety standards, ensuring the production of the highest quality products.
Healthcare Pharmaceuticals Limited (HPL) proudly presents its Oncology Facility, a state-of-the-art establishment dedicated to the production of high-quality anti-cancer products. Established in 2015, the facility spans 18,648 square feet, strategically designed across four levels to optimize production efficiency. The floor is dedicated to the manufacturing of various anti-cancer medications, including tablets, capsules, liquids, and lyophilized injections, all produced within a sophisticated containment system.
Healthcare Pharmaceuticals Limited (HPL) proudly introduces its Cephalosporin Unit, a specialized facility dedicated to the manufacturing of high-quality cephalosporin antibiotics. Established in December 2019, this state-of-the-art facility spans three production floors, each designed to optimize the production of both sterile and solid dosage forms while maintaining strict quality standards.
Healthcare Pharmaceuticals Limited (HPL) proudly introduces its dedicated Hormone Unit, established in November 2018. This advanced facility is designed for the production of both contraceptive and non-contraceptive hormone products, including tablets and sterile injections, all manufactured in a controlled and specialized environment. Spanning three levels, the Hormone Unit is strategically located within the same premises as HPL’s other facilities but maintains complete separation of processes to ensure product integrity and safety. The facility includes specialized areas for storage, production, packaging, laboratories, and utility support.
Healthcare Pharmaceuticals Limited (HPL) is proud to introduce its General Sterile and Ophthalmic Unit, established in December 2012. This specialized facility is dedicated to the production of high-quality sterile products, including ophthalmic and injectable forms, within a controlled environment. Spanning three levels, the unit is strategically located within HPL’s premises to ensure complete separation of processes and optimized production flow. The design of the facility incorporates separate storage, production, packaging, laboratory, and utility areas, all meticulously structured to uphold the highest safety and quality standards.
Healthcare Pharmaceuticals Limited (HPL) proudly introduces its Inhaler Manufacturing Unit, a specialized facility established in December 2012 to meet the growing demand for high-quality inhalation products. Designed with meticulous attention to quality and safety, this unit operates across three levels and is equipped to produce both Metered Dose Inhalers (MDIs) and Dry Powder Inhalers (DPIs). Each area within the facility is optimized to ensure safe, efficient production under strict environmental controls.
Healthcare Pharmaceuticals Limited (HPL) is excited to present its Topical Production Unit, dedicated to the manufacturing and packaging of high-quality creams, ointments, and medicated gels. Established in 2010, this facility has been designed with a strong emphasis on health and safety standards, ensuring that all products are produced in a controlled and compliant environment. The existing Topical Production Facility features advanced HVAC and water systems that contribute to optimal manufacturing conditions and product integrity.
The warehouse (approx.2000 Sq. m) is connected with the general oral solid manufacturing building by a dedicated corridor at the back side. Two air locks are used to transfer materials from the Warehouse to general oral solid manufacturing area. One is for transfer of raw and primary packaging materials to the Product expose zone (manufacturing and primary packaging area) and the other one is to transfer packaging materials to Product not expose Zone (secondary packaging area).
Healthcare Pharmaceuticals Limited (HPL) is pleased to present its Vaccine Manufacturing Unit, a state-of-the-art facility established in December 2012 to meet the growing global demand for high-quality human vaccines. The facility has been designed with precision, ensuring safety, efficiency, and adherence to the strictest quality standards. Spanning three levels, it also includes a dedicated utility building to support all operational requirements. Each area within the facility has been carefully arranged to optimize production workflows while maintaining strict safety and quality protocols.